NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,558,000 | +60.3% | 90,704 | +2.2% | 0.20% | -24.4% |
| Q3 2015 | $972,000 | -19.4% | 88,717 | -19.1% | 0.27% | -38.6% |
| Q1 2015 | $1,206,000 | +581.4% | 109,612 | +859.8% | 0.43% | +365.6% |
| Q4 2014 | $177,000 | -23.7% | 11,420 | -36.8% | 0.09% | +43.1% |
| Q2 2014 | $232,000 | +48.7% | 18,062 | +31.7% | 0.06% | +124.1% |
| Q4 2013 | $156,000 | -81.6% | 13,710 | -83.1% | 0.03% | -84.7% |
| Q3 2013 | $846,000 | – | 81,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |